| Literature DB >> 28883319 |
Guocheng Wang1, Hala Zreiqat2.
Abstract
Metallic biomaterials like stainless steel, Co-based alloy, Ti and its alloys are widely used as artificial hip joints, bone plates and dental implants due to their excellent mechanical properties and endurance. However, there are some surface-originated problems associated with the metallic implants: corrosion and wear in biological environments resulting in ions release and formation of wear debris; poor implant fixation resulting from lack of osteoconductivity and osteoinductivity; implant-associated infections due to the bacterial adhesion and colonization at the implantation site. For overcoming these surface-originated problems, a variety of surface modification techniques have been used on metallic implants, including chemical treatments, physical methods and biological methods. This review surveys coatings that serve to provide properties of anti-corrosion and anti-wear, biocompatibility and bioactivity, and antibacterial activity.Entities:
Keywords: antibacterial; bioactivity; biocompatibility; corrosion; metal; surface modification; wear
Year: 2010 PMID: 28883319 PMCID: PMC5445792 DOI: 10.3390/ma3073994
Source DB: PubMed Journal: Materials (Basel) ISSN: 1996-1944 Impact factor: 3.623
Figure 1The outline of this review paper.
Summary of the anti-corrosion ZrN coatings.
| Composition | Substrates | Methods | Electrolyte | Ref. |
|---|---|---|---|---|
| ZrN/Zr | biomedical AZ91 magnesium alloy | filtered cathodic arc deposition | simulated body fluids (SBF) | [ |
| Zr, ZrN and ZrN/Zr | AISI 304 stainless steel | Hollow cathode discharge ion plating | 0.5 M H2SO4 containing 0.05M KSCN | [ |
| ZrN0.83/Zr | NiTi shape-memory alloy | plasma immersion ion implantation and deposition | Hank’s Solution | [ |
| ZrN,TiN and Ti/TiN | 316 L stainless steel | reactive magnetron sputtering | pH 5.6 acetic acid and sodium acetate buffer solution. | [ |
| ZrN and ZrN-Ag nanocomposite | AISI 316 L surgical steel, and medical grade Ti-Al-V | reactive unbalanced magnetron sputtering | 3.5% NaCl solution | [ |
| TiN and ZrN | Plain carbon steel | an unbalanced magnetron sputtering technique/low or mild energetic ion bombardment with high flux | sulfuric acid solution (1N) | [ |
Summary of anti-corrosion TiN coatings.
| Ref. | Substrate | Methods | Electrolyte |
|---|---|---|---|
| [ | 316-L stainless steel | reactive magnetron sputtering | pH 5.6 acetic acid and sodium acetate buffer solution |
| [ | Plain carbon stee (Ck35) | unbalanced magnetron sputtering technique | 1 N sulfuric acid solution |
| [ | Biomedical NiTi shape memory alloy | plasma immersion ion implantation and deposition (PIIID) | Hank’s solution |
| [ | 1Cr11Ni2W2MoV Martensitic stainless steel | hollow cathode ionic plating (HCIP) | 0.5 mol/L NaCl and 1mol/L H2SO4 diluted aqueous solution |
| [ | Ti-6Al-4V | plasma assisted electron beam PVD technique | 0.5 N NaCl solution |
| [ | NiTi coated Si | dc magnetron sputtering | 1 mol/L NaCl solution |
| [ | Biomedical AISI 316L stainless steel | arc ion plating | neutral Troyde’s simulated body fluid |
Properties of the biologically relevant calcium orthophosphate. (Reproduced with permission from Prof. Epple, M. [121])
| Ca/P ratio | Compound | Formula | Solubility at 25oC, –log(Ksp) | Solubility at 37 oC, –log(Ksp) | pH stability range in aqueous solution at 25 oC |
|---|---|---|---|---|---|
| 0.5 | monocalcium phosphate monohydrate (MCPM) | Ca(H2PO4)2·H2O | 1.14 | no data | 0.0–2.0 |
| 0.5 | monocalcium phosphate anhydrate | Ca(H2PO4)2 | 1.14 | no data | [d] |
| 1.0 | diacalcium phosphate dehydrate (DCPD, “brushite”) | CaHPO4·2H2O | 6.59 | 6.63 | 2.0–6.0 |
| 1.0 | diacalcium phosphate anhydrate (DCPA, “monetite”) | CaHPO4 | 6.90 | 7.02 | [d] |
| 1.33 | octacalcium phosphate (OCP) | Ca8(HPO4)2(PO4)4·5H2O | 96.6 | 95.9 | 5.5–7.0 |
| 1.5 | α-tricalcium phosphate (α-TCP) | α-Ca3(PO4)2 | 25.5 | 25.5 | [b] |
| 1.5 | β-tricalcium phosphate (β -TCP) | β-Ca3(PO4)2 | 28.9 | 29.5 | [b] |
| 1.2-2.2 | amorphous calcium phosphate (ACP) | Cax(PO4)y·nH2O | [c] | [c] | [c] |
| 1.5–1.67 | Calcium-deficient hydroxyapatite (CDHA) | Ca10-x(HPO4)x(PO4)6-x(OH)2-x (0 < x < 1) | ≈ 85.1 | ≈ 85.1 | ≈ 6.5–9.5 |
| 1.67 | hydroxyapatite | Ca10(PO4)6(OH)2 | 116.8 | 117.2 | 9.5–12 |
| 2.0 | tetracalcium phosphate (TTCP) | Ca4(PO4)2O | 38–44 | 37–42 | [b] |
The solubility is given as the logarithm of the ion product of the given formulae (excluding hydrate water) with concentrations in mol/L. [b] these compounds cannot be precipitated from aqueous solution). [c] cannot be measured precisely. However, the following values were reported: 25.7 ± 0.1 (pH 7.40), 29.9 ± 0.1 (pH 6.00), 32.7 ± 0.1 (pH 5.28). [d] Stable at temperatures above 100 °C. [e] Always metastable. The composition of a precipitate depends on the solution pH values and composition [121].
Summary of surface techniques for depositing Ca & P coatings on metal implants and their characteristics.
| Methods | Characteristics |
|---|---|
| Dip and immersion coating | High temperature for post-sintering HA layer can degrade the strength of the metal and impair the interfacial adhesion and cause the decomposition of HA |
| Electrophoresis deposition | Low bond strength and non-uniform thickness of the coating |
| Hot isostatic pressing | Difficult to seal borders on implants with complex shapes, high temperature during the process may denature HA |
| Solution deposition | A low temperature deposition method resulting in a pure, highly crystalline, firmly adherent coating |
| Sputtering deposition | A line-of-sight technique with low deposition rate and high cost, but the coatings are dense and with uniform thickness on flat substrates |
| Thermal spraying | A line-of-sight technique with high deposition rates and low cost; high temperature may cause decomposition of HA; high cooling rate may result in the formation of nanostructure, coatings usually have micro-rough surface |
| Sol-gel | Not a line-of-sight technique suitable for coating substrates with complex shapes; processing temperature is low; raw materials are expansive and sometimes including organic toxic solvent. |
| Biomimetic coating | Low processing temperature technique capable of coating complex-shaped substrates; time-consuming |
| Laser deposition | Be capable to restore complex stoichiometries and to produce crystalline and highly adherent coatings, but process temperature may cause the oxidation of metal or alloy substrates. |
Figure 2Schematic maps of typical IBSD and IBAD process (a) IBSD. (b) IBAD.
Figure 3Comparison of bone-like apatite formation on plasma sprayed CaO-SiO2 based bioceramic coatings after immersion in SBF solution: (a) CaSiO3 coating immersed in SBF solution for 1 day. (b). Ca2SiO4 coating immersed in SBF solution for 1 day. (c) CaMgSi2O6 coating immersed in SBF solution for 5 days. (Figure 3a and b are reprinted with the permission from Liu, X.Y. [204,205]; Figure 3c is reprinted with the permission from Xue, W.C. [207])
Summary of bioactive oxide coatings.
| Coating | Coating method | Ref. | Post-treatments | Phase | Influencing factors in bioactivity |
|---|---|---|---|---|---|
| TiO2 | Solution precursor plasma spray process | [ | Chemically treated in 5M NaOH solution at 80 °C | Rutile | Formation of Ti-OH groups |
| Sol-gel | [ | none | Anatase | Surface topography; charge; charge density | |
| [ | 450 °C, 2 h | Anatase | Abundant Ti-OH groups and negatively charged surfaces | ||
| [ | Heat-treatment | Anatase | Crystal structure: anatase show more ability to induce apatite formation in SBF than rutile | ||
| Plasma spraying & plasma immersion ion implantation (PIII) | [ | Hydrogen incorporation by PIII | Rutile (bulk) & anatase (surface) | Combination of nanostructure and hydrogen incorporation can endow the coating with bioactivity | |
| Cathodic electrolytic deposition | [ | None | Anatase (subcrystalline) | Crystal structure | |
| Below 300 °C | Anatase | ||||
| Above 500 °C | Rutile | ||||
| Anodic oxidation | [ | H2SO4 and Na2SO4 solutions | rutile or rutile/anatase | Crystal structure: amorphous titania cannot induce apatite formation in SBF solution | |
| CH3COOH and H3PO4 solutions | amorphous titania | ||||
| ZrO2 | Plasma spraying | [ | None | Tetragonal (CaO-ZrO2) | Nanostructured surface; crystal structure |
| None | Monoclinic (undoped ZrO2) | ||||
| Cathodic arc deposition | [ | None | Tetragonal (undoped ZrO2) | Nanostructured surface | |
| Micro-arc oxidation | [ | None | Monoclinic and small amount of tetragonal ZrO2 | Basic Zr-OH group | |
| NaOH treatment | |||||
| [ | Ultraviolet (UV) irradiation | Monoclinic and small amount of tetragonal ZrO2 | |||
| SiO2 | Sol-gel | [ | Heat-treatment at 400 °C for 2 h | amorphous silica | Silanol group (Si-OH) |
Figure 4Comparison of bone-like apatite formation on plasma sprayed zirconia coatings after immersed in SBF solution for 28 days. (a) undoped zirconia coating. (b) zirconia coating stabilized 12.8 mol % calcia. (c) zirconia coating stabilized with 16 mol % calcia. (d) zirconia coating stabilized with 30 mol % calcia.
Summary of different methods to immobilize bioactive molecules onto the surface of metallic implants.
| Immobilization method | Biological molecule | Substrate and pre-treatment | Results | Ref. | |
|---|---|---|---|---|---|
| Adsorption | Bone morphogenetic protein-3 (BMP-3) | Corundum-blasted Titanium alloy; Hydroxyapatite coated Titanium alloy; Ti coated Titanium alloy | BMP-3 coated samples showed more ability to induce new bone formation compared to those without BMP-3 | [ | |
| Covalent immobilization | by chemical pretreatment | Synthetic receptor binding motif mimicking BMP-2 | 3-aminopropyltriethoxysilane (APTES) coated Titanium | enhance the rate of bone healing as compared with untreated Ti surfaces | [ |
| Laminin and human epidermal growth factors (EGF) | Silanized TiO2-film Silanisation by reaction of GPTS1 | Significantly reduce the amount of irreversibly adsorbed salivary proteins | [ | ||
| Heparin | Silanized and oxidized Titanium Oxidization by H2SO4/30% H2O2 or annealing at 750 °C; Silanisation by being boiled in APMS2 contained toluene soltution | The remaining activity of heparin is depending on the chain length of spacer | [ | ||
| by plasma-based modification | Fibronectin | Plasma polymerization of HMDSO3 on Titanium | Enhanced adsorption of fibronectin | [ | |
| BMP-4 | Plasma polymerization of allyl amine on Titanium alloy | Surfaces with BMP-4 are initially able to induce ALP activity in C3H10T1/2 cells, long term effect is depending on the concentration of surface amino group | [ | ||
| Incorporation with carriers | Recombinant human BMP-2 (rhBMP-2) | Turned or surface etched Titanium dental implant Absorbable Collagen sponge (ACS) | rhBMP-2/ACS significantly enhances the effect of guided bore regeneration (GBR) | [ | |
| BMP-2; insulin-like growth factor-1 and transforming growth factor-β1 | Titanium Kirschner wires incorporated with poly(D,L-lactide) (PDLLA) | Significantly accelerate the fracture healing | [ | ||
GPTS1: (3-glycidyloxypropyl)trimethoxysilane; APMS2: 3-(Trimethoxysilyl)-propylamine; HMDSO3: Hexamethyldisiloxane
Summary of inorganic antibacterial agents studied in biomedical coating applications.
| Inorganic agents | Coatings | Coating methods | Testing bacteria | Note | Ref. | |
|---|---|---|---|---|---|---|
| Ag-related agent | TiN/Ag multilayered films | ion beam assisted deposition | Antibacterial activity is depending on the modulation period | [ | ||
| Silver doped perfluoropolyether-urethane coatings | Coating /evapration | Antibacterial activity is depending on the release of Ag ions | [ | |||
| TiO2-Ag coating | Plasma electrolytic oxidation in Ag nanoparticle- contained electrolyte | Possibly, antibacterial activity is due to the close contact of bacteria with Ag particles and the release of Ag ions | [ | |||
| polyethylene terephthalate implanted with Ag ion | Ion beam implantation | Ag exists in the form of Ag2CO3 and Ag2O | [ | |||
| Poly(vinyl alcohol) / AgNO3 | Solution/evaporation | Ag ions can release from the composite coating | [ | |||
| Silver doped SiO2 film | Sol-gel | Reduction of Ag+ ion is affected by the annealing temperature | [ | |||
| Non-Ag agent | F | F--implanted titanium | Ion implantation | Antibacterial activity was supposed to be caused by the formation of a metal fluoride complex on the surfaces | [ | |
| C | Carbon film | Plasma sputtering for H-free film | α-C:H film showed relatively poor antibacterial activity compared with hydrogen-free carbon films | [ | ||
| TiO2 | TiO2 film | plasma source ion implantation followed by annealing | Antibacterial activity is due to the photocatalytic bactericidal effect | [ | ||
| TiO2 film | A flame-assisted CVD to deposit SiO2, and thermal APCVD to deposit TiO2 | [ | ||||
| DLC films containing TiO2 nanoparticles | plasma-enhanced chemical vapor deposition | Enhanced antibacterial activity are contributed by the increased hydrophilicity and the decreased interfacial energy of bacteria adhesion | [ | |||
| ZnO | ZnO coated glass | Ultrasonic irradiation | The antibacterial activity is due to the generation of the reactive-oxygen-species (ROS) products | [ | ||
Scheme 1Reaction of NO with amines to produce diazeniumdiolate NO donors [315].
Summary of antimicrobial peptides (AmPs) used to functionalize films and corresponding incorporation methods.
| Antimicrobial peptides | Amino acid sequence | Coating methods | Ref. |
|---|---|---|---|
| Defensin | ATCDLASGFGVGSSLCAAHCIARRYRGGYCNSKAVCVCRN | LbL | [ |
| Chromofungin | RILSILRHQNLLKELQDLAL | LbL | [ |
| Magainin I | GIGLPLHSAGLPGLAPVGGIMLS | SAMs | [ |
| Gramicidine A | VGALAVVVWLWLWLW | LbL | [ |
| LL-37 | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES | One-pot EISA | [ |
| Ponericin G1 | GWKDWAKKAGGWLKKKGPGMAKAALKAAMQ | LbL | [ |
Figure 5Typical schematic diagram of layer by layer (LbL) methods: (A) The immobilization of peptides is through mixing peptides and the polyanions. (B) The immobilization of peptides is through adsorption onto the pre-existing polyanion layer.
Figure 6Schematic map of the incorporation of LL-37 into mesoporous silica films by one-pot EISA [329].